Receptor activator of nuclear factor-kappa B is enriched in CD9-positive extracellular vesicles released by osteoclasts

Abstract

Aim: Receptor activator of nuclear factor-kappa B (RANK)-containing extracellular vesicles (EVs) bind RANK-Ligand (RANKL) on osteoblasts, and thereby simultaneously inhibit bone resorption and promote bone formation. Because of this, they are attractive candidates for therapeutic bone anabolic agents. Previously, RANK was detected in 1 in every 36 EVs from osteoclasts by immunogold electron microscopy. Here, we have sought to characterize the subpopulation of EVs from osteoclasts that contains RANK in more detail.

Methods: The tetraspanins CD9 and CD81 were localized in osteoclasts by immunofluorescence. EVs were visualized by transmission electron microscopy. A Single Particle Interferometric Reflectance Imaging Sensor (SP-IRIS) and immunoaffinity isolations examined whether RANK is enriched in specific types of EVs.

Results: Immunofluorescence showed CD9 was mostly on or near the plasma membrane of osteoclasts. In contrast, CD81 was localized deeper in the osteoclast’s cytosolic vesicular network. By interferometry, both CD9 and CD81 positive EVs from osteoclasts were small (56-83 nm in diameter), consistent with electron microscopy. The CD9 and CD81 EV populations were mostly distinct, and only 22% of the EVs contained both markers. RANK was detected by SP-IRIS in 2%-4% of the CD9-containing EVs, but not in CD81-positive EVs, from mature osteoclasts. Immunomagnetic isolation of CD9-containing EVs from conditioned media of osteoclasts removed most of the RANK. A trace amount of RANK was isolated with CD81.

Conclusion: RANK was enriched in a subset of the CD9-positive EVs. The current study provides the first report of selective localization of RANK in subsets of EVs.

Keywords

Exosomes / microvesicles / bone / remodeling / Single Particle Interferometric Reflectance Imaging Sensor / RANKL reverse signaling

References

[1] Lacey DL,Tan HL.Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.Cell1998;93:165-76

[2] Yasuda H,Nakagawa N.Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.Proc Natl Acad Sci U S A1998;95:3597-602 PMCID:PMC19881

[3] Compston JE,Leslie WD.Osteoporosis.Lancet2019;393:364-76

[4] Bone HG,Brandi ML.10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension.Lancet Diabetes Endocrinol2017;5:513-23

[5] Lipton A,Stopeck AT.Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics.Eur J Cancer2016;53:75-83

[6] Deng L,Peng Y.Osteoblast-derived microvesicles: a novel mechanism for communication between osteoblasts and osteoclasts.Bone2015;79:37-42

[7] Cappariello A,Muraca M,Rucci N.Osteoblast-derived extracellular vesicles are biological tools for the delivery of active molecules to bone.J Bone Miner Res2018;33:517-33

[8] Huynh N,Smith D.Characterization of regulatory extracellular vesicles from osteoclasts.J Dent Res2016;95:673-9 PMCID:PMC4924543

[9] Holliday LS,Rody WJ Jr.RANKL and RANK in extracellular vesicles: surprising new players in bone remodeling.Extracell Vesicles Circ Nucleic Acids2021;2:18-28

[10] Liu H,Su JC.Engineered mammalian and bacterial extracellular vesicles as promising nanocarriers for targeted therapy.Extracell Vesicles Circ Nucleic Acids2022;3:63-86.

[11] Marton N,Baricza E.Extracellular vesicles regulate the human osteoclastogenesis: divergent roles in discrete inflammatory arthropathies.Cell Mol Life Sci2017;74:3599-611

[12] Ikebuchi Y,Honma M.Coupling of bone resorption and formation by RANKL reverse signalling.Nature2018;561:195-200

[13] Kobayashi-Sun J,Kondo M.Uptake of osteoblast-derived extracellular vesicles promotes the differentiation of osteoclasts in the zebrafish scale.Commun Biol2020;3:190 PMCID:PMC7181839

[14] Sims NA.Osteoclasts provide coupling signals to osteoblast lineage cells through multiple mechanisms.Annu Rev Physiol2020;82:507-29

[15] Zhang S,Huang P.The affinity of human RANK binding to its ligand RANKL.Arch Biochem Biophys2009;487:49-53

[16] Yang Z,Ding L.Nanoengineering multifunctional extracellular vesicles availably mitigate bone loss in osteoporosis through binding to RANKL and rebalancing the Treg/Th17 cells.Chem Eng J2023;467:143391

[17] Kong YY,Sarosi I.OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis.Nature1999;397:315-23

[18] Kong YY,Penninger JM.Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development.Immunol Cell Biol1999;77:188-93

[19] Daaboul GG,Benussi L.Digital detection of exosomes by interferometric imaging.Sci Rep2016;6:37246 PMCID:PMC5112555

[20] Silva AM,Gunnarsson A.Quantification of protein cargo loading into engineered extracellular vesicles at single-vesicle and single-molecule resolution.J Extracell Vesicles2021;10:e12130 PMCID:PMC8329990

[21] Hurst IR,Jiang J.Actin-related protein 2/3 complex is required for actin ring formation.J Bone Miner Res2004;19:499-506

[22] Vracar TC,Park J.Enoxacin and bis-enoxacin stimulate 4T1 murine breast cancer cells to release extracellular vesicles that inhibit osteoclastogenesis.Sci Rep2018;8:16182 PMCID:PMC6212457

[23] Murray JB,Han G,Rody WJ Jr.Activation of (pro)renin by (pro)renin receptor in extracellular vesicles from osteoclasts.Sci Rep2021;11:9214 PMCID:PMC8080643

[24] Rody WJ Jr,Emory-Carter AK.The proteome of extracellular vesicles released by clastic cells differs based on their substrate.PLoS One2019;14:e0219602 PMCID:PMC6619814

[25] Rody WJ Jr,Spicer V.The use of cell culture platforms to identify novel markers of bone and dentin resorption.Orthod Craniofac Res2017;20 Suppl 1:89-94 PMCID:PMC8220388

[26] Ishii M,Koike M.RANKL-induced expression of tetraspanin CD9 in lipid raft membrane microdomain is essential for cell fusion during osteoclastogenesis.J Bone Miner Res2006;21:965-76

[27] Yi T,Cho JY.Tetraspanin CD9 regulates osteoclastogenesis via regulation of p44/42 MAPK activity.Biochem Biophys Res Commun2006;347:178-84

[28] Takeda Y,Miyado K.Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes.J Cell Biol2003;161:945-56 PMCID:PMC2172976

[29] Sone E,Ikebuchi Y.The induction of RANKL molecule clustering could stimulate early osteoblast differentiation.Biochem Biophys Res Commun2019;509:435-40

[30] Mathieu M,Jouve M.Specificities of exosome versus small ectosome secretion revealed by live intracellular tracking of CD63 and CD9.Nat Commun2021;12:4389 PMCID:PMC8289845

[31] Iwai K,Ohshima S,Saeki Y.Abundant expression of tetraspanin CD9 in activated osteoclasts in ovariectomy-induced osteoporosis and in bone erosions of collagen-induced arthritis.Rheumatol Int2008;28:225-31

[32] Mathieu M,Lavieu G.Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication.Nat Cell Biol2019;21:9-17

[33] Iwai K,Ohshima S,Saeki Y.Expression and function of transmembrane-4 superfamily (tetraspanin) proteins in osteoclasts: reciprocal roles of Tspan-5 and NET-6 during osteoclastogenesis.Allergol Int2007;56:457-63

[34] Ouweneel AB,Sorci-Thomas MG.The ins and outs of lipid rafts: functions in intracellular cholesterol homeostasis, microparticles, and cell membranes: thematic review series: biology of lipid rafts.J Lipid Res2020;61:676-86 PMCID:PMC7193959

[35] Elsherbini A,Zhu Z.Extracellular vesicles containing ceramide-rich platforms: “mobile raft” isolation and analysis.Methods Mol Biol2021;2187:87-98